John W. Walsh Alpha-1 Home Infusion Act of 2025
The summary
What this bill does
John W. Walsh Alpha-1 Home Infusion Act of 2025
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Legislative timeline
From introduction
Mar 25, 2025
Introduced & referred to committee
Congressional support
Sponsors & Cosponsors
U.S. Representative - FL District 27 · R-FL
52 cosponsors
U.S. Representative - ME District 1 · D-ME
U.S. Representative - NJ District 4 · R-NJ
U.S. Representative - GA District 4 · D-GA
U.S. Representative - UT District 4 · R-UT
U.S. Representative - DC · D-DC
Member of Congress · R-CA
U.S. Representative - NC District 7 · R-NC
Member of Congress · D-NY
U.S. Representative - NY District 26 · D-NY
U.S. Representative - NY District 17 · R-NY
Member of Congress · R-NY
New Jersey Governor · D-NJ
+ 40 more cosponsors
Roll-call vote
The vote, by member
The vote, by member
VERSION CHANGES
What changed,
and where.
Loading the bill text comparison.
Bill Metadata
| Congress | 119 |
| Bill Type | HR |
| Bill Number | 2343 |
| Origin Chamber | House |
| Current Status | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| Policy Area | Health |
| Primary Committee | Not assigned |
| Introduced | March 25, 2025 |
| Latest Action | March 25, 2025 |
| Cosponsors | 52 · House vote — · — views |